SPONSOR
Navy General Hospital, Beijing
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 1, Phase 2, Phase 2, Phase 3
Conditions studied: Relapsed Classic Hodgkin LymphomaRefractory Classic Hodgkin LymphomaHigher-risk Myelodysplastic SyndromesPrimary Central Nervous System Lymphoma
Navy General Hospital, Beijing is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Relapsed Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma, Higher-risk Myelodysplastic Syndromes, Primary Central Nervous System Lymphoma.
The trial portfolio spans Phase 2, Phase 1, Phase 2, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Navy General Hospital, Beijing
How many clinical trials has Navy General Hospital, Beijing sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Navy General Hospital, Beijing, of which 3 are actively recruiting participants. These trials cover conditions including Relapsed Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma, Higher-risk Myelodysplastic Syndromes. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Navy General Hospital, Beijing research focus on?
Navy General Hospital, Beijing clinical trials span Relapsed Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma, Higher-risk Myelodysplastic Syndromes, Primary Central Nervous System Lymphoma. The research pipeline includes Phase 2, Phase 1, Phase 2, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Navy General Hospital, Beijing clinical trial?
To participate in a Navy General Hospital, Beijing trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Navy General Hospital, Beijing trials with current recruitment status updated daily.
Clinical Trials by Navy General Hospital, Beijing
NCT06190067 Phase 2
Recruiting
Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma
Relapsed Classic Hodgkin Lymphoma
NCT06471946 Phase 1, Phase 2
Recruiting
VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS
Higher-risk Myelodysplastic Syndromes
NCT02657785 Phase 2, Phase 3
Recruiting
Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy
Primary Central Nervous System Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology